The RxView Blog

Real world data, analytics, and insights for healthcare decision makers

Advera Health Analytics, Inc.

Evidex Goes Global - VigiBase Drug Safety Data Access

November 22, 2017

world.pngLast week we announced the addition of VigiBase global safety data to the Evidex platform. VigiBase is the unique global database of individual safety reports collected from over 110 countries by the World Health Organization. It totals over 15 million adverse event reports since 1968 and is administered by the Uppsala Monitoring Centre in Sweden.

This is an exciting development for our company, for our clients, and for the drug safety community at large.

Since our earliest days at Advera Health, our core focus as been to make FDA’s Adverse Event Reporting System (FAERS) data easily accessible and actionable for our clients. While FAERS pulls in adverse event reports from patients outside the U.S., it is highly concentrated by U.S. medications and submissions by U.S. patients and healthcare provides. Adding the VigiBase data allows us to have a more global perspective on medication use and patient safety with approximately 15 million reports from over 100 countries that cover 90% of the world’s population.

As these data are coded similarly to FAERS, we will be able to leverage the research and technology we’ve developed over the years and apply many of the same data optimization and management techniques. This will unleash the real power of Vigibase. When included in Evidex, VigiBase can be navigated in the same simple-to-use approach that our clients have come to expect, putting the power of signal detection across disparate datasets in the hands of all users. Alongside Advera’s proprietary clinical trials safety outcomes data and the other datasets Evidex natively supports, Evidex will continue to exemplify Pharmacovigilance 2.0 - the next generation of signal detection, management, and mitigation from multiple real world data sources.

For our clients and the drug safety community at large, providing access to VigiBase data through Evidex is a big step toward better pharmacovigilance. To date, accessing these data has been difficult with limited options. Shifting VigiBase data onto a modern analysis platform like Evidex will expand the use of these data and accelerate the learnings gleaned from the different participating countries.

To learn more visit our VigiBase in Evidex information site.

Topics: FAERS, Evidex, Pharmacovigiance 2.0, VigiBase

New Call-to-action

Subscribe to Email Updates